Action Intercos - ICOS

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

14,26

Prix Achat

14,00

Prix Vente

14,36

Volume échangé

124 724

13,90 Fourchette du Jour 14,28

12,76 Plage de 52 semaines 16,92

Clôture Veille

13,84

Ouverture

13,94

Dernière Transaction

155

14.26

Dernière heure de transaction

Volume moyen (3 m)

81 286

Volume financier

VWAP

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

- Worldwide Sales of Cialis Top $233 Million - - Net Income Grows to $75.8 Million for 2006 Second Quarter - BOTHELL, Wash., and INDIANAPOLIS...

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

New Survey Reveals State of Emotional and Physical Intimacy of Boomer Relationships BOTHELL, Wash. and INDIANAPOLIS, June 22...

Lilly ICOS LLC Reports Results for First Quarter of 2006

- Cialis Attains Leading ED Market Share Position in Eleven Countries - BOTHELL, Wash. and INDIANAPOLIS, Ind., April 20 /PRNewswire-FirstCall/...

Lilly ICOS LLC Reports First Full-Year Profit in its History

- 2005 Fourth Quarter Net Income Surges to $61.4 Million - - 2005 Worldwide Sales Grow 35% - - Company Provides Update on Clinical Plan for BPH...

Lilly ICOS LLC Reports First Quarterly Profit in its History

BOTHELL, Wash. and INDIANAPOLIS, Ind., Oct. 20 /PRNewswire-FirstCall/ -- Lilly ICOS LLC (Lilly ICOS) (NYSE:LLYNYSE:andNYSE:Nasdaq:NYSE:ICOS) is...

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

-- National Survey Shows Misconceptions Still Prevalent: Nearly One in Three Believe Tight Underwear Can Lead to Erectile Dysfunction NEW YORK...

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Cialis(R), since...

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level -- Luke Donald Artwork, Original Vignettes...

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comorbid Conditions SAN...

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France - Cialis Achieves 49% of Total Tablet...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.44	3.18379160637	13.82	14.32	13.74	53046	13.95557299	DE
4	0.26	1.85714285714	14	14.38	13.1	65467	13.86102096	DE
12	0.76	5.62962962963	13.5	15.06	13.1	81286	14.06488553	DE
26	-1.42	-9.05612244898	15.68	16.58	13.1	90578	14.61768781	DE
52	-0.56	-3.77867746289	14.82	16.92	12.76	85465	14.77053855	DE
156	1.52	11.9309262166	12.74	16.92	9.755	62688	14.1662551	DE
260	-0.204	-1.41039823009	14.464	17.1	9.755	62445	14.21469186	DE

ICOS - Frequently Asked Questions (FAQ)

What is the current Intercos share price?

The current share price of Intercos is 14,26 €

What is the 1 year trading range for Intercos share price?

Intercos has traded in the range of 12,76 € to 16,92 € during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
WPAL26Palingeo SpA	0,1948 € (25,68%)	8
1SPCEVirgin Galactic Holdings Inc	5,00 € (24,97%)	20
OLIOlidata Spa	2,399 € (24,60%)	836,64k
WHIK26Haiki Spa	0,127 € (20,95%)	275
1PNEPNE AG	12,82 € (16,97%)	700
GTGT Talent Group SpA	0,51 € (-27,14%)	2,25k
1SQBlock Inc	67,00 € (-16,02%)	236
1AKAMAkamai Tech	79,50 € (-15,48%)	8
WIVN26iVision Tech SpA	0,388 € (-13,74%)	6,2k
1UNHUnitedhealth Group Inc	439,50 € (-9,30%)	520
TITTelecom Italia SpA	0,2714 € (0,11%)	206,69M
SPMSaipem Spa	2,327 € (2,02%)	27,03M
TITRTelecom Italia	0,3105 € (-0,48%)	25,61M
A2AA2A Spa	2,15 € (0,84%)	13,75M
ISPIntesa Sanpaolo Spa	4,5125 € (0,52%)	11,42M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intercos Spa (ICOS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

ICOS Dernières nouvelles

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

Lilly ICOS LLC Reports Results for First Quarter of 2006

Lilly ICOS LLC Reports First Full-Year Profit in its History

Lilly ICOS LLC Reports First Quarterly Profit in its History

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

ICOS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intercos Spa (ICOS) Cours

Intercos Spa (ICOS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

ICOS Dernières nouvelles

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

Lilly ICOS LLC Reports Results for First Quarter of 2006

Lilly ICOS LLC Reports First Full-Year Profit in its History

Lilly ICOS LLC Reports First Quarterly Profit in its History

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

ICOS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités